Skip to main content
Log in

Inhalative Kombinationstherapie bei chronisch obstruktiver Lungenerkrankung

TRISTAN-Studie

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. http://www.goldcopd.com

  2. Hanania NA, Darken P, Horstman D et al. (2003) The efficacy and safety of fluticasone propionate (250 microg) / salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. Chest 124: 834–843

    Article  CAS  PubMed  Google Scholar 

  3. Mahler DA, Wire P, Horstman D et al. (2002) Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 1084–1091

    Google Scholar 

  4. Szafranski W, Cukier A, Ramirez A et al. (2003) Efficacy and safety of budesonide / formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 21: 74–81

    Google Scholar 

Download references

Interessenkonflikt:

Keine Angaben.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. Seeger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seeger, W., Schulz, R. Inhalative Kombinationstherapie bei chronisch obstruktiver Lungenerkrankung. Internist 45, 727–728 (2004). https://doi.org/10.1007/s00108-004-1177-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-004-1177-8

Navigation